Have we applied? I have never heard that we ask fo

Quote:

---

Have we applied? I have never heard that we ask for any assistance.

---

That's a fair question.

I think you are saying that the government cannot force a private company to accept funding. And we all know that there are compelling reasons to NOT take money as I believe it conveys rights and privileges to the funder that may be antithetical to a small company's business model. And yet I find myself wondering why Big Pharma never seems to have a problem with that part of the equation.

Anyway, that still begs the question of why the FDA / government did not at least help us to enroll our trials, or buy all of the available (or future) inventory as they did with Regeneron -- especially in the face of our eIND results. Let's face it, the US is going to buy it anyway, and CytoDyn could have used the money to advance the trials or order more product from Samsung.

It is clear that the US government is throwing money around like a drunken sailor. And they have been doing it as far back, if not before, when they tried to buy German vaccine maker CureVac for an unlimited amount of money.

Source Link: https://www.marketwatch.com/story/germany-inv...2020-06-15

The stakes could not be higher. This pandemic is a national security issue, and the fate of our economy (not to mention, the world's) hinges on a therapeutic or vaccine. There is no exaggeration or hyperbole in the previous statements.

If leronlimab is approved, the US will not only want enough doses to treat Americans with the virus -- it will want to build a massive stockpile that can be used to address the very real possibility that a vaccine may not be possible, or may only offer protection for a matter of months. This virus could last for the rest of our lives.

And once the government begins to understand that leronlimab is a broad-based therapeutic whose MOA is virus-agnostic, and therefore applicable to future viruses and pandemics that have not even hit our shores, the desire to build a stockpile will increase exponentially.

And the exact same realization will happen in every nation in the world.

I have quietly observed various posters (on this board and others) stating that leronlimab order for COVID indication will never reach the hundreds of millions of doses. In my opinion, that is one of the most short-sighted statements I have ever heard.

Our country alone will want hundreds of millions of doses, for the current pandemic (which might last for years -- or might last for the rest of our lives), and for the next pandemic which hasn't even arrived yet. And then there's the very possible use of leronlimab for prophylaxis and post-virus "long haulers". Now, multiply that out by the number of other countries in the world.

If one cannot envision how COVID orders could be in the hundreds of millions -- then you're not living in my version of reality.

Setting aside your very reasonable point regarding CytoDyn's application (or not) for funding, why would't the government have at least helped to increase trial enrollment, increase production, or make offers to buy all of the available product for the foreseeable future?

The only explanation I can think of is that Dr.NP has been lying to us about the progressively dwindling production numbers he's been stating. He started in April with a potential 5 million vials supplied by Samsung and 600-700k from AGC. Now he's telling us it is 1.1 million from Samsung and AGC is nowhere to be found.

Are we to believe the 4 million missing vials have been quietly allocated to the the US? I doubt it. I think time dragged on, money got tight, Samsung booked their bioreactors in the absence of any firm orders (other than the one that Dr.NP allegedly helped to fund), and who knows what happened to AGC (there's something wrong with that, especially since Dr.NP has somehow decided to not discuss this anymore).

So, funding aside, with eIND results that any other Big Pharmaceutical company would pay billions to have for themselves -- why is CytoDyn barely able to enroll their trials, and why are they only able to provide 1.1M vials this year?

In the face of extraordinary suffering and death, and an economy literally teetering on ruin, this entire scenario makes absolute no sense to me.